Medical Devices

Overview

We partner with medical device manufacturers in the United States and abroad to bring revolutionary products to market, navigate industry regulations, protect designs, drive business growth, and enhance and execute overall business strategies. Our regulatory counsel team manages interactions with governmental agencies, including the Centers for Medicaid and Medicare Services and the Food and Drug Administration, and our government affairs professionals help to identify and mobilize strategies for prompt product approvals and to respond to the challenges and capitalize on the opportunities presented by new regulations and changes in the marketplace. Whether developing a new product, seeking to enter a new market, or pursuing a strategic acquisition or affiliation, our regulatory, corporate, transactional, and IP attorneys leverage industry-specific insights to help medical device companies advance their goals.

Insights & Events

Latest

最新 July 2026

Unlocking the Right to Repair: The Expanding Compliance Landscape

Divergent state legislation, federal antitrust litigation, congressional proposals, and an evolving executive-branch posture
20 min read
Speaking Engagement Recap July 29, 2026

Tariffs, Trade Policy, and Supply Chains Under Pressure: Critical Considerations for Life Sciences Companies Operating in High-Stakes International Markets

ACI’s 13th Annual Summit for Women Leaders in Life Sciences Law
1 min read
最新 July 2026

The Intel Report: Quarterly National Security Briefing — 2026 Q2

Key Regulatory Developments and Enforcement Actions Affect National Security Priorities, Risks, and Opportunities across Sectors
24 min read
News July 2026

Minnesota Lawyer Recognizes Richard Bennett and Kelly Fermoyle as 2026 ‘Up & Coming Attorneys’

1 min read
Speaking Engagement Recap June 20, 2026

Florida IP Litigation & Regional Innovation

2026 Federal Circuit Bar Association Bench & Bar® Conference
1 min read
News June 2026

The Legal 500 United States 2026 Guide Recognizes Faegre Drinker Practices and Attorneys

2 min read
最新 May 2026

EU AI Act High-Risk Systems — European Commission Issues Draft Guidelines

Practical Implications for US Companies and Actions to Be Taking Now
11 min read
最新 May 2026

Multimillion-Dollar Trade Secret Verdict Reversed by Federal Circuit Due to Prior Disclosure in Patents and Self-Evident Concepts in California Case

International Medical Devices, Inc. v. Cornell, No. 25-1843 (Fed. Cir. April 17, 2026)
4 min read
最新 April 2026

FDA-Related Legislative and Regulatory Proposals and Funding Change the President's FY27 Budget

Between a Doorstop and a Starting Gun
121 min read
最新 April 2026

Minnesota PFAS Reporting: Deadline Extension and Enhanced Support

The Initial Reporting Deadline Is Extended to September 15, 2026
4 min read
Insights
最新 July 2026

Unlocking the Right to Repair: The Expanding Compliance Landscape

Divergent state legislation, federal antitrust litigation, congressional proposals, and an evolving executive-branch posture
20 min read
最新 July 2026

The Intel Report: Quarterly National Security Briefing — 2026 Q2

Key Regulatory Developments and Enforcement Actions Affect National Security Priorities, Risks, and Opportunities across Sectors
24 min read
最新 May 2026

EU AI Act High-Risk Systems — European Commission Issues Draft Guidelines

Practical Implications for US Companies and Actions to Be Taking Now
11 min read
最新 May 2026

Multimillion-Dollar Trade Secret Verdict Reversed by Federal Circuit Due to Prior Disclosure in Patents and Self-Evident Concepts in California Case

International Medical Devices, Inc. v. Cornell, No. 25-1843 (Fed. Cir. April 17, 2026)
4 min read
最新 April 2026

FDA-Related Legislative and Regulatory Proposals and Funding Change the President's FY27 Budget

Between a Doorstop and a Starting Gun
121 min read
最新 April 2026

Minnesota PFAS Reporting: Deadline Extension and Enhanced Support

The Initial Reporting Deadline Is Extended to September 15, 2026
4 min read
最新 February 2026

US and International Developments in Artificial Intelligence

Artificial Intelligence Briefing
6 min read
最新 January 2026

Key Updates in FDA’s 2026 General Wellness and Clinical Decision Support Software Guidance

Greater Clarity, Transparency, and Alignment in Digital Health Regulation
9 min read
媒体报道 January 2026

Joanne Lewers Shares Insights With Law360 on Major 2025 FTC Merger Challenges

1 min read
最新 December 2025

Significant Drug & Device Developments of 2025

Drug & Device Companies Need to Be Vigilant and Nimble in Adapting to These Shifts
17 min read

Meet The Team

Meet The Team